These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12546116)

  • 1. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
    Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of the russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia.
    Jacobs B; Clowes C; Wares F; Polivakho V; Lyagoshina T; Peremitin G; Banatvala N
    Int J Tuberc Lung Dis; 2002 May; 6(5):396-405. PubMed ID: 12019915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of an alternative tuberculosis management strategy for permanent farm dwellers in South Africa amidst health service contraction.
    Clarke M; Dick J; Bogg L
    Scand J Public Health; 2006; 34(1):83-91. PubMed ID: 16449048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
    Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the costs and treatment success of collaborative arrangements among public and private providers for tuberculosis control in Indonesia.
    Johns B; Probandari A; Mahendradhata Y; Ahmad RA
    Health Policy; 2009 Dec; 93(2-3):214-24. PubMed ID: 19729220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reforming tuberculosis control in Ukraine: results of pilot projects and implications for the national scale-up of DOTS.
    Vassall A; Chechulin Y; Raykhert I; Osalenko N; Svetlichnaya S; Kovalyova A; van der Werf MJ; Turchenko LV; Hasker E; Miskinis K; Veen J; Zaleskis R
    Health Policy Plan; 2009 Jan; 24(1):55-62. PubMed ID: 19056804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of DOTS in urban Brazil.
    Mohan CI; Bishai D; Cavalcante S; Chaisson RE
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):27-32. PubMed ID: 17217126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.
    Migliori GB; Khomenko AG; Punga VV; Ambrosetti M; Danilova I; Ribka LN; Grzemska M; Sawert H; Raviglione MC
    Bull World Health Organ; 1998; 76(5):475-83. PubMed ID: 9868838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
    Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.
    Migliori GB; Ambrosetti M; Besozzi G; Farris B; Nutini S; Saini L; Casali L; Nardini S; Bugiani M; Neri M; Raviglione MC
    Bull World Health Organ; 1999; 77(6):467-76. PubMed ID: 10427931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment.
    Au-Yeung KY; DiCarlo L
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1498-504. PubMed ID: 23006834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost determinants of tuberculosis management in a low-prevalence country.
    Bocchino M; Greco S; Rosati Y; Mattioli G; Marruchella A; De Mori P; Bibbolino C; Girardi E; Squarcione S; Saltini C
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):146-52. PubMed ID: 16499252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment.
    Khan MA; Walley JD; Witter SN; Imran A; Safdar N
    Health Policy Plan; 2002 Jun; 17(2):178-86. PubMed ID: 12000778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador.
    Rouzier VA; Oxlade O; Verduga R; Gresely L; Menzies D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1316-22. PubMed ID: 20843424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance in pulmonary tuberculosis patients using directly observed treatment short course.
    Dosumu EA
    Afr J Med Med Sci; 2001; 30(1-2):111-4. PubMed ID: 14510163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt.
    Morsy AM; Zaher HH; Hassan MH; Shouman A
    East Mediterr Health J; 2003 Jul; 9(4):689-701. PubMed ID: 15748066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOTS expansion: will we reach the 2005 targets?
    Véron LJ; Blanc LJ; Suchi M; Raviglione MC
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):139-46. PubMed ID: 14974757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana.
    Moalosi G; Floyd K; Phatshwane J; Moeti T; Binkin N; Kenyon T
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S80-5. PubMed ID: 12971658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.